These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Antigens onto bare skin: a 'painless' paradigm shift in vaccine delivery. Partidos CD Expert Opin Biol Ther; 2003 Sep; 3(6):895-902. PubMed ID: 12943448 [TBL] [Abstract][Full Text] [Related]
51. Decision-making at the surface of the intact or barrier disrupted skin: potential applications for vaccination or therapy. Partidos CD; Muller S Cell Mol Life Sci; 2005 Jul; 62(13):1418-24. PubMed ID: 15818468 [TBL] [Abstract][Full Text] [Related]
52. Microneedles for vaccine delivery: challenges and future perspectives. Shin CI; Jeong SD; Rejinold NS; Kim YC Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151 [TBL] [Abstract][Full Text] [Related]
53. Effective and lesion-free cutaneous influenza vaccination. Wang J; Li B; Wu MX Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5005-10. PubMed ID: 25848020 [TBL] [Abstract][Full Text] [Related]
56. Transcutaneous immunization with influenza vaccines. Skountzou I; Kang SM Curr Top Microbiol Immunol; 2009; 333():347-68. PubMed ID: 19768414 [TBL] [Abstract][Full Text] [Related]
57. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. Babiuk S; Baca-Estrada M; Babiuk LA; Ewen C; Foldvari M J Control Release; 2000 May; 66(2-3):199-214. PubMed ID: 10742580 [TBL] [Abstract][Full Text] [Related]
58. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249 [TBL] [Abstract][Full Text] [Related]